Every experimental or clinical study may raise controversial ethical issues (e.g., Institutional Ethical Approval for working with animal or human subjects). Thus, Journal of Renal Edndocrinology (JRE) expects all authors, reviewers and editors to consider COPE, ICMJE and Equator Network’s reporting guidelines in medical ethics plus scientific writing. If any, authors should state related declaration(s), otherwise the following sentence should be given “None to be declared". Please take a look at the review process in JRE.
The cover letter must include a statement declaring that the study complies with current ethical considerations.
Ethical issues (including plagiarism, misconduct, data fabrication, falsification, double publication or redundancy) must completely considered by the authors.
Authors reporting experimental studies on human subjects must include a statement of assurance in the Materials and Methods section of the manuscript reading that: (1) informed consent was obtained from each patient enrolled in the study and (2) the study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the institution's human research committee. In studies involving animal experimentation, provide assurance that all animals received humane care according to the criteria outlined in the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by the National Institutes of Health (NIH publication 86-23 revised 1985).
DUTIES OF EDITORS
The editors of JRE are responsible for deciding which of the articles submitted to the journal should be published. They are guided by the policies of the journal’s editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. They actively work to improve the quality of the journal.
The editor evaluate manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.
The editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.
Disclosure and conflicts of interest
Unpublished materials disclosed in a submitted manuscript must not be used in an editor’s own research without the express written consent of the author.
DUTIES OF REVIEWERS
Contribution to Editorial Decisions
Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author improving the paper.
Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.
Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.
Standards of Objectivity
Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.
In case, any attempt of plagiarism is brought to our attention accompanied with convincing evidence, following steps would be taken:
(a) After consulting the respective Editorial Board Members, authors guilty of plagiarism will be debarred from publishing their papers in Journal of Renal Edndocrinology (JRE).
(b) Heads of the Departments/Institutes of the offending authors will be intimated of such incidences of plagiarism.
c) In case of confirmation of plagiarism on an already published article, the Editor will be obliged to withdraw the article from the journal website.
Editorial Freedom at the JRE
TheJREis an international peer-reviewed journal which will publish articles relevant to protection/prevention of renal failure. The JRE adheres to the World Association of Medical Editors (WAME) Policy on “The Relationship between Journal Editors-in-Chief and Owners [http://www.wame.org/resources/policies# independence]” .More specifically, the Editor-in-Chief has editorial independence and as such has full authority over the journal’s editorial content including how and when information is published. Editorial decisions are based solely on the validity of the work and its importance to readers, not on the policies or commercial interests of the owner. The JRE is a publication of Nickan Research Institute. Neither the Nickan research Institute, nor other organizations interferes in the evaluation, selection or editing of individual articles, either directly or by creating an environment in which editorial decisions are influenced.
Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Guidelines for Filing a Competing Interest Statement
Definition: Conflict of interest (COI) exists when there is a divergence between an individual’s private interests (competing interests) and his or her responsibilities to scientific and publishing activities such that a reasonable observer might wonder if the individual’s behavior or judgment was motivated by considerations of his or her competing interests. COI in medical publishing affects everyone with a stake in research integrity including journals, research/academic institutions, funding agencies, the popular media, and the public.
COI may exist in numerous forms including financial ties, academic commitments, personal relationships, political or religious beliefs, and institutional affiliations. In managing COI, The JREabides to the policy statement of the WAME. All authors should declare their COI, if any, during the manuscript submission. Reviewers are asked to declare their COI after they accept to review a manuscript. Editors should also declare their COI during handling of a manuscript.
Managing COI depends on disclosure because it is not possible to routinely monitor or investigate whether competing interests are present. COI disclosed by authors will be presented in the Editorial Board and an appropriate action will be taken. Those reviewers and Editors with COI will be excluded from the manuscript process. If competing interests’ surface from other sources after a manuscript is submitted or published, The JRE investigates allegations of COI and depending on their nature, appropriate actions will be taken if the allegations were found to be true. If a manuscript has been published and COI surfaces later, the journal will publish the results of the investigation as a correction to the article and ask the author to explain, in a published letter, why the COI was not revealed earlier.
Disposal of Material
Once published, all copies of the manuscript, correspondence and artwork will be held for at least one year before disposal.
Journal of Renal Endocrinology (JRE) will not tolerate plagiarism and manuscripts will be rejected, or articles retracted after publication based on unethical conduct by the authors. In cases of suspected plagiarism, necessary actions as recommended by the Committee on Publication Ethics (COPE) guidelines will be followed.
Ethical considerations must be addressed in the Materials and Methods section. 1) In the case of clinical trials, state that informed consent was obtained from all human adult participants and from the parents or legal guardians of minors. Include the name of the appropriate institutional review board that approved the project. 2) When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the last update of Helsinki Declaration (http://www.icmje.org). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. 3) Indicate in the text that the maintenance and care of experimental animals complies with National Institutes of Health guidelines for the humane use of laboratory animals, or those of your institute or agency.